Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With Rhinoconjunctivitis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Allergy

Interventions

BIOLOGICAL

ToleroMune Ragweed

ToleroMune Ragweed dose 1x4 administrations 2 weeks apart

BIOLOGICAL

Placebo

Placebo comparator, 1x4 administrations 2 weeks apart

Trial Locations (1)

Centre de Recherche Appliqué en Allergie de Québec, Québec